Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecopipam in Tourette's Syndrome in Children and Adolescents
NCT02102698Phase 2Completed
- Sponsor
- Emalex Biosciences
- Start
- Jun 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ecopipam in Tourette syndrome (TS), sponsored by Emalex Biosciences. Started Jun 2014; status: completed.
02
Drugs
ecopipam
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT02102698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02102698.